Biotech, Diagnostics, Medical Device, Pharmaceutical and other life sciences companies face truly unique challenges.  They operate in a business context that includes:

• Regulated environments where every country has unique rules and structures
• Long product development life cycles with great uncertainties of product success
• Increasingly complex market dynamics fraught with competition from generics, global players, and new delivery mechanisms
• Complex networks of constituents: patients, general practitioners, specialists, payors, regulators, and distributors
• Saturation levels amongst physicians for sales rep time and a need to find new ways to engage with prescribers and KOLs
• Demanding customers (since life and death can hang in the balance) where scientific proof and subject matter mastery make a difference

Grail Research helps life sciences organizations gather, analyze and package the data they need to make informed business decisions in this increasingly challenging environment.  Our capabilities are particularly well-aligned with key challenges your organization faces:

• We help optimize initial and on-going product launch strategies
• We identify and evaluate business development opportunities in inefficiently covered or emerging areas
• We ensure clinical, regulatory and commercial strategies remain well-positioned 

Our flexible approach and staff of MDs and technically literate research professionals have made us the research firm of choice for some of the world’s largest and smallest life sciences organizations. 

Our expertise covers Biotechnology, Diagnostics, Devices, Pharmaceuticals and Healthcare Policy.  We have experience in a wide range of therapeutic areas including:

• Cardiovascular
• Central Nervous System
• Gynecology
• Oncology
• Ophthalmology
• Respiratory